Names | |
---|---|
IUPAC name
2-Bromo-N-carbamoyl-2-ethylbutanamide | |
Identifiers | |
| |
3D model (JSmol) |
|
ChEMBL | |
ChemSpider |
|
ECHA InfoCard | 100.000.952 |
EC Number |
|
KEGG |
|
MeSH | carbromal |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C7H13BrN2O2 | |
Molar mass | 237.097 g·mol−1 |
Appearance | White crystals |
Odor | Odourless |
Density | 1.544 g/cm3 |
Melting point | 119 °C (246 °F; 392 K) |
Soluble | |
Solubility | soluble in chloroform, ether, acetone, benzene |
log P | 1.623 |
Acidity (pKa) | 10.69 |
Basicity (pKb) | 3.31 |
Structure | |
rhombic | |
Pharmacology | |
N05CM04 (WHO) | |
Related compounds | |
Related ureas |
Bromisoval |
Related compounds |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Carbromal is a hypnotic/sedative originally synthesized in 1909 by Bayer and subsequently marketed as Adalin.[1][2] The drug was later sold by Parke-Davis in combination with pentobarbital, under the name Carbrital.[3]
Diethylmalonic acid [510-20-3] (1) is decarboxylated to 2-ethylvaleric acid [20225-24-5] (2). The Hell-Volhard-Zelinsky reaction converts this to 2-Bromo-2-Ethylbutyryl Bromide [26074-53-3] (3). Reaction with urea with affords carbromal (4).
| |
---|---|
Alcohols |
|
Barbiturates |
|
Benzodiazepines |
|
Carbamates |
|
Flavonoids |
|
Imidazoles |
|
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols |
|
Piperidinediones |
|
Pyrazolopyridines |
|
Quinazolinones |
|
Volatiles/gases |
|
Others/unsorted |
|
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators |
This sedative-related article is a stub. You can help Wikipedia by expanding it. |